title: Tackling latency as a barrier to an HIV cure: what next?
authors.affiliation: Department of Infectious Diseases, Assistance publique-Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France; Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Unité Mixte de Recherche en Santé 1136, Inserm, Paris, France; Université Pierre et Marie Curie Paris 06, Sorbonne Universités, F75013, Paris, France. Electronic address: christine.katlama@psl.aphp.fr.
authors.forename: Christine
authors.initials: C
authors.lastname: Katlama
authors.affiliation: Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Unité Mixte de Recherche en Santé 1136, Inserm, Paris, France; Université Pierre et Marie Curie Paris 06, Sorbonne Universités, F75013, Paris, France.
authors.forename: Dominique
authors.initials: D
authors.lastname: Costagliola
authors.affiliation: Department of Immunology, Assistance publique-Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France; Centre d'Immunologie et Maladies Infectieuses Paris, Inserm U1135, Paris, France.
authors.forename: Brigitte
authors.initials: B
authors.lastname: Autran
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D015496:CD4-Positive T-Lymphocytes; D004197:Disease Reservoirs; D006678:HIV; D015483:HIV Antibodies / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy; D015497:HIV-1; D054884:Host-Pathogen Interactions; D006801:Humans; D014775:Virus Activation; D017735:Virus Latency
chemical_list: D019380:Anti-HIV Agents; D015483:HIV Antibodies